Tumor profiling is a foundation of precision oncology, allowing for a thorough knowledge of a cancer's genetic, molecular, and cellular properties. The session "Tumor Profiling" highlights methodologies and applications that direct individualized treatment strategies and enhance patient outcomes.".
Tumor profiling entails the examination of DNA, RNA, proteins, and other molecular markers to find mutations, patterns of gene expression, and signaling pathways that promote cancer growth. Such information assists clinicians in choosing targeted agents, immunotherapies, or combined therapies based on each patient's tumor profile. Sophisticated technologies like next-generation sequencing, liquid biopsies, and proteomics improve the accuracy and accessibility of profiling.
The session also delves into the place of tumor heterogeneity in the response to therapy and drug resistance. Through the comprehension of variations within and among tumors, clinicians are able to modify treatment regimens, track disease progression, and detect developing resistances. Incorporation with bioinformatics and artificial intelligence enhances the interpretation of data and informs clinical decision-making.
Participants will learn about methodologies, clinical utility, and future directions in tumor profiling. This session highlights the importance of comprehensive tumor characterization in precision oncology to deliver better, more personalized, and adaptive cancer treatments while enhancing survival and quality of life for patients
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
